SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+44.83%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$294M
AUM Growth
+$294M
(+1.3%)
Cap. Flow
-$70.4M
Cap. Flow
% of AUM
-23.93%
Top 10 Holdings %
Top 10 Hldgs %
94.39%
Holding
16
New
1
Increased
5
Reduced
1
Closed
1
Top Buys
| 1 |
RPRX
Repros Therapeutics Inc.
RPRX
|
$7.66M |
| 2 |
Amgen
AMGN
|
$5.33M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$2.37M |
| 4 |
KIN
Kindred Biosciences, Inc.
KIN
|
$2.35M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$1.49M |
Top Sells
| 1 |
IDIX
IDENIX PHARMACEUTICALS INC
IDIX
|
$73.5M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$17.4M |
Sector Composition
| 1 | Healthcare | 69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
1
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $76.4M | 25.99% | 12,000,000 | – | – |
|
|
IDIX
2
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $48.2M | 16.39% | 2,000,000 -3,050,100 | -60% | -$73.5M |
|
3
Quest Diagnostics
DGX
$20.3B
| $45.5M | 15.47% | 775,000 | – | – |
|
|
BRLI
4
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $38.7M | 13.16% | 1,280,984 | – | – |
|
5
Merck
MRK
$210B
| $23.1M | 7.87% | 400,000 | – | – |
|
|
RPRX
6
DELISTED
Repros Therapeutics Inc.
RPRX
| $17.4M | 5.9% | 1,003,367 +442,767 | +79% | +$7.66M |
|
|
VVUS
7
DELISTED
Vivus Inc
VVUS
| $13.7M | 4.66% | 2,573,943 | – | – |
|
|
8
Amgen
AMGN
$155B
| $5.33M | 1.81% | +45,000 | New | +$5.33M |
|
|
AVEO
9
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $4.7M | 1.6% | 2,570,759 | – | – |
|
|
10
Enanta Pharmaceuticals
ENTA
$180M
| $4.52M | 1.54% | 105,000 +55,000 | +110% | +$2.37M |
|
|
KIN
11
DELISTED
Kindred Biosciences, Inc.
KIN
| $4.25M | 1.45% | 228,126 +126,301 | +124% | +$2.35M |
|
12
Labcorp
LH
$23.1B
| $3.87M | 1.32% | 37,824 | – | – |
|
|
ITCI
13
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.63M | 1.23% | 215,202 +88,507 | +70% | +$1.49M |
|
14
Gyre Therapeutics
GYRE
$703M
| $2.84M | 0.97% | 630,000 +300,484 | +91% | +$1.36M |
|
15
Traws Pharma
TRAW
$9.89M
| $1.9M | 0.65% | 350,000 | – | – |
|
|
MNK
16
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – | -274,895 | Closed | -$17.4M |
|